First Manhattan CO Astrazeneca PLC Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Astrazeneca PLC stock. As of the latest transaction made, First Manhattan CO holds 6,425 shares of AZN stock, worth $430,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,425

Previous 6,425 -0.0%

Holding current value

$430,089

Previous $501,000 0.2%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $66 - $80	1 Added 0.02%	6,425 $501,000
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $549 - $626	-9 Reduced 0.14%	6,424 $435,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $7,241 - $8,105	-117 Reduced 1.79%	6,433 $433,000
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $215,392 - $233,570	3,081 Added 88.82%	6,550 $468,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $120,300 - $136,398	-1,905 Reduced 35.45%	3,469 $240,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $28,406 - $36,910	524 Added 10.8%	5,374 $364,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $50,369 - $128,962	950 Added 24.36%	4,850 $265,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $66,672 - $72,948	-1,200 Reduced 23.53%	3,900 $234,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $183,996 - $228,684	-3,800 Reduced 42.7%	5,100 $305,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $36,549 - $42,191	775 Added 9.54%	8,900 $442,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $29,092 - $37,334	-675 Reduced 7.67%	8,125 $429,000
Q2 2018 Aug 01, 2018	BUY	$34.55 - $37.05 $138,200 - $148,200	4,000 Added 83.33%	8,800 $308,000
Q1 2018 Apr 20, 2018	SELL	$32.97 - $36.63 $118,692 - $131,868	-3,600 Reduced 42.86%	4,800 $167,000
Q4 2017 Jan 22, 2018	SELL	$32.09 - $34.78 $38,508 - $41,736	-1,200 Reduced 12.5%	8,400 $291,000
Q3 2017 Oct 25, 2017	BUY	$28.96 - $34.0 $278,016 - $326,400	9,600	9,600 $325,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Astrazeneca PLC Transaction History